Epidemiology and clinical course of COVID-19 in Shanghai, China
Background: Novel coronavirus pneumonia (COVID-19) is prevalent around the world. We aimed to describe epidemiological features and clinical course in Shanghai. Methods: We retrospectively analysed 325 cases admitted at Shanghai Public Health Clinical Center, between January 20 and February 29, 2020. Results: 47.4% (154/325) had visited Wuhan within 2 weeks of illness onset. 57.2% occurred in 67 clusters; 40% were situated within 53 family clusters. 83.7% developed fever during the disease course. Median times from onset to first medical care, hospitalization and negative detection of nucleic acid by nasopharyngeal swab were 1, 4 and 8 days. Patients with mild disease using glucocorticoid tended to have longer viral shedding in blood and feces. At admission, 69.8% presented with lymphopenia and 38.8% had elevated D-dimers. Pneumonia was identified in 97.5% (314/322) of cases by chest CT scan. Severe-critical patients were 8% with a median time from onset to critical disease of 10.5 days. Half required oxygen therapy and 7.1% high-flow nasal oxygen. The case fatality rate was 0.92% with median time from onset to death of 16 days. Conclusion: COVID-19 cases in Shanghai were imported. Rapid identification, and effective control measures helped to contain the outbreak and prevent community transmission.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2020 |
---|---|
Erschienen: |
2020 |
Enthalten in: |
Zur Gesamtaufnahme - volume:9 |
---|---|
Enthalten in: |
Emerging microbes & infections - 9(2020), 1 vom: 04. Dez., Seite 1537-1545 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Shen, Yinzhong [VerfasserIn] |
---|
Links: |
---|
Themen: |
COVID-19 |
---|
Anmerkungen: |
Date Completed 14.07.2020 Date Revised 05.03.2024 published: Print Citation Status MEDLINE |
---|
doi: |
10.1080/22221751.2020.1787103 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM311518834 |
---|
LEADER | 01000caa a22002652 4500 | ||
---|---|---|---|
001 | NLM311518834 | ||
003 | DE-627 | ||
005 | 20240305231825.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231225s2020 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1080/22221751.2020.1787103 |2 doi | |
028 | 5 | 2 | |a pubmed24n1317.xml |
035 | |a (DE-627)NLM311518834 | ||
035 | |a (NLM)32573353 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Shen, Yinzhong |e verfasserin |4 aut | |
245 | 1 | 0 | |a Epidemiology and clinical course of COVID-19 in Shanghai, China |
264 | 1 | |c 2020 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 14.07.2020 | ||
500 | |a Date Revised 05.03.2024 | ||
500 | |a published: Print | ||
500 | |a Citation Status MEDLINE | ||
520 | |a Background: Novel coronavirus pneumonia (COVID-19) is prevalent around the world. We aimed to describe epidemiological features and clinical course in Shanghai. Methods: We retrospectively analysed 325 cases admitted at Shanghai Public Health Clinical Center, between January 20 and February 29, 2020. Results: 47.4% (154/325) had visited Wuhan within 2 weeks of illness onset. 57.2% occurred in 67 clusters; 40% were situated within 53 family clusters. 83.7% developed fever during the disease course. Median times from onset to first medical care, hospitalization and negative detection of nucleic acid by nasopharyngeal swab were 1, 4 and 8 days. Patients with mild disease using glucocorticoid tended to have longer viral shedding in blood and feces. At admission, 69.8% presented with lymphopenia and 38.8% had elevated D-dimers. Pneumonia was identified in 97.5% (314/322) of cases by chest CT scan. Severe-critical patients were 8% with a median time from onset to critical disease of 10.5 days. Half required oxygen therapy and 7.1% high-flow nasal oxygen. The case fatality rate was 0.92% with median time from onset to death of 16 days. Conclusion: COVID-19 cases in Shanghai were imported. Rapid identification, and effective control measures helped to contain the outbreak and prevent community transmission | ||
650 | 4 | |a Journal Article | |
650 | 4 | |a COVID-19 | |
650 | 4 | |a clinical characteristics | |
650 | 4 | |a clinical course | |
650 | 4 | |a epidemiology | |
650 | 4 | |a viral shedding | |
700 | 1 | |a Zheng, Fang |e verfasserin |4 aut | |
700 | 1 | |a Sun, Danfeng |e verfasserin |4 aut | |
700 | 1 | |a Ling, Yun |e verfasserin |4 aut | |
700 | 1 | |a Chen, Jun |e verfasserin |4 aut | |
700 | 1 | |a Li, Feng |e verfasserin |4 aut | |
700 | 1 | |a Li, Tao |e verfasserin |4 aut | |
700 | 1 | |a Qian, Zhiping |e verfasserin |4 aut | |
700 | 1 | |a Zhang, Yuyi |e verfasserin |4 aut | |
700 | 1 | |a Xu, Qingnian |e verfasserin |4 aut | |
700 | 1 | |a Liu, Li |e verfasserin |4 aut | |
700 | 1 | |a Huang, Qin |e verfasserin |4 aut | |
700 | 1 | |a Shan, Fei |e verfasserin |4 aut | |
700 | 1 | |a Xu, Lie |e verfasserin |4 aut | |
700 | 1 | |a Wu, Jun |e verfasserin |4 aut | |
700 | 1 | |a Zhu, Zhaoqin |e verfasserin |4 aut | |
700 | 1 | |a Song, Zhigang |e verfasserin |4 aut | |
700 | 1 | |a Li, Shenyang |e verfasserin |4 aut | |
700 | 1 | |a Shi, Yuxin |e verfasserin |4 aut | |
700 | 1 | |a Zhang, Jianliang |e verfasserin |4 aut | |
700 | 1 | |a Wu, Xueyun |e verfasserin |4 aut | |
700 | 1 | |a Mendelsohn, Joshua B |e verfasserin |4 aut | |
700 | 1 | |a Zhu, Tongyu |e verfasserin |4 aut | |
700 | 1 | |a Lu, Hongzhou |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Emerging microbes & infections |d 2012 |g 9(2020), 1 vom: 04. Dez., Seite 1537-1545 |w (DE-627)NLM249608804 |x 2222-1751 |7 nnns |
773 | 1 | 8 | |g volume:9 |g year:2020 |g number:1 |g day:04 |g month:12 |g pages:1537-1545 |
856 | 4 | 0 | |u http://dx.doi.org/10.1080/22221751.2020.1787103 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 9 |j 2020 |e 1 |b 04 |c 12 |h 1537-1545 |